Santel Donald J 4
4 · Oyster Point Pharma, Inc. · Filed Aug 3, 2021
Insider Transaction Report
Form 4
Santel Donald J
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-07-30+4,765→ 4,765 totalExercise: $14.25Exp: 2021-07-30→ Common Stock (4,765 underlying) - Award
Stock Option (Right to Buy)
2021-07-30+10,405→ 10,405 totalExercise: $14.25Exp: 2021-07-30→ Common Stock (10,405 underlying) - Award
Common Stock
2021-07-30+6,937→ 6,937 total - Award
Common Stock
2021-07-30+3,177→ 10,114 total
Footnotes (5)
- [F1]Represents a grant of restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
- [F2]These RSUs will vest over three years (on the same day of the month as the grant date) with one-third (1/3) vesting annually, in each case subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2019 Equity Incentive Plan (the "Plan")) through each such date.
- [F3]These RSUs will vest on June 7, 2022, but will vest fully on the date of the Company's next annual meeting of stockholders held after the date of grant if not fully vested on such date, subject to the Reporting Person continuing to be a Service Provider through such date.
- [F4]One-third (1/3) of the shares subject to the option shall vest on the 12 month anniversary of the grant date and the remainder will vest at one-twentyfourth (1/24th) per month thereafter (on the same day of the month as the grant date), subject to the Reporting Person continuing to be a Service Provider through each such date.
- [F5]One-eleventh (1/11th) of the Shares subject to the Option shall vest monthly beginning on August 7, 2021 and on the same day monthly thereafter, but will vest fully on the date of the Issuer's next annual meeting of stockholders held after the date of grant if not fully vested on such date, subject to the Reporting Person continuing to be a Service Provider through each such date.